Breast cancer: The good, the bad, and an important call to effective risk reduction strategies.
作者信息
Kaklamani Virginia G, Arteaga Carlos L
机构信息
Mays Cancer Center, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA.
Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, Texas, USA.
出版信息
CA Cancer J Clin. 2024 Nov-Dec;74(6):471-474. doi: 10.3322/caac.21867. Epub 2024 Oct 1.
Abstract
摘要
相似文献
1
Breast cancer: The good, the bad, and an important call to effective risk reduction strategies.乳腺癌：益处、弊端及对有效降低风险策略的重要呼吁。
CA Cancer J Clin. 2024 Nov-Dec;74(6):471-474. doi: 10.3322/caac.21867. Epub 2024 Oct 1.
2
Good versus bad news consultations in advanced breast cancer: the role of empathy in information recall - an observational study.晚期乳腺癌中的坏消息与好消息告知：共情在信息回忆中的作用——一项观察性研究
BMJ Support Palliat Care. 2023 Mar 27. doi: 10.1136/spcare-2022-003938.
3
Tumor Talk and Child Well-Being: Perceptions of "Good" and "Bad" News Among Parents of Children With Advanced Cancer.肿瘤话题与儿童福祉：晚期癌症患儿家长对“好”消息和“坏”消息的认知
J Pain Symptom Manage. 2017 May;53(5):833-841. doi: 10.1016/j.jpainsymman.2016.11.013. Epub 2017 Jan 3.
4
Non-canonical BAD activity regulates breast cancer cell and tumor growth via 14-3-3 binding and mitochondrial metabolism.非规范 BAD 活性通过与 14-3-3 结合和线粒体代谢调节乳腺癌细胞和肿瘤的生长。
Oncogene. 2019 May;38(18):3325-3339. doi: 10.1038/s41388-018-0673-6. Epub 2019 Jan 11.
5
Breaking bad news: a primer for radiologists in breast imaging.传达坏消息：乳腺影像科放射科医生入门指南
J Am Coll Radiol. 2007 Nov;4(11):800-8. doi: 10.1016/j.jacr.2007.06.009.
6
The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer.人乳腺癌中的磷酸化膜雌激素受体及细胞质信号传导与凋亡蛋白
Cancer. 2008 Sep 15;113(6):1489-95. doi: 10.1002/cncr.23699.
7
Expression of the apoptosis-related genes BCL-2 and BAD in human breast carcinoma and their associated relationship with chemosensitivity.凋亡相关基因 BCL-2 和 BAD 在人乳腺癌中的表达及其与化疗敏感性的相关性。
J Exp Clin Cancer Res. 2010 Aug 7;29(1):107. doi: 10.1186/1756-9966-29-107.
8
Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence.好人还是坏人？野生型p53在激素依赖性乳腺癌的起源、治疗和复发中的双重性
Cancers (Basel). 2018 May 31;10(6):172. doi: 10.3390/cancers10060172.
9
BAD sensitizes breast cancer cells to docetaxel with increased mitotic arrest and necroptosis.BAD 使乳腺癌细胞对多西他赛敏感，导致有丝分裂阻滞和坏死性凋亡增加。
Sci Rep. 2020 Jan 15;10(1):355. doi: 10.1038/s41598-019-57282-1.
10
BCL-2 family protein, BAD is down-regulated in breast cancer and inhibits cell invasion.BCL-2 家族蛋白 BAD 在乳腺癌中表达下调，抑制细胞侵袭。
Exp Cell Res. 2015 Feb 1;331(1):1-10. doi: 10.1016/j.yexcr.2014.11.016. Epub 2014 Dec 9.
引用本文的文献
1
lnc-MTRNR2L12-3 derived from hypoxic breast cancer cell exosomes facilitates angiogenesis via the Src/FAK signaling pathway.源自缺氧乳腺癌细胞外泌体的lnc-MTRNR2L12-3通过Src/FAK信号通路促进血管生成。
Med Oncol. 2025 Jun 25;42(8):280. doi: 10.1007/s12032-025-02836-9.
2
Application of the Monaco-serial biological function for cardiac dose constraints in DIBH-IMRT treatment planning for left-sided breast cancer.摩纳哥系列生物学功能在左侧乳腺癌深吸气屏气调强放疗治疗计划中心脏剂量限制中的应用
Front Oncol. 2025 Jun 9;15:1610980. doi: 10.3389/fonc.2025.1610980. eCollection 2025.
本文引用的文献
1
The Lancet Breast Cancer Commission.《柳叶刀》乳腺癌委员会
Lancet. 2024 May 11;403(10439):1895-1950. doi: 10.1016/S0140-6736(24)00747-5. Epub 2024 Apr 15.
2
Breast cancer risk prediction using machine learning: a systematic review.使用机器学习进行乳腺癌风险预测：一项系统综述。
Front Oncol. 2024 Mar 20;14:1343627. doi: 10.3389/fonc.2024.1343627. eCollection 2024.
3
Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.多柔比星暴露与青少年和成年霍奇金淋巴瘤幸存者的乳腺癌风险。
J Clin Oncol. 2024 Jun 1;42(16):1903-1913. doi: 10.1200/JCO.23.01386. Epub 2024 Feb 15.
4
Analysis of Breast Cancer Mortality in the US-1975 to 2019.美国乳腺癌死亡率分析-1975 年至 2019 年。
JAMA. 2024 Jan 16;331(3):233-241. doi: 10.1001/jama.2023.25881.
5
A Systematic Review and Critical Assessment of Breast Cancer Risk Prediction Tools Incorporating a Polygenic Risk Score for the General Population.一项针对纳入多基因风险评分的一般人群乳腺癌风险预测工具的系统评价与批判性评估。
Cancers (Basel). 2023 Nov 12;15(22):5380. doi: 10.3390/cancers15225380.
6
Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapy.新辅助化疗后残留乳腺癌的肿瘤微环境与远处复发的种族差异。
NPJ Breast Cancer. 2023 Jun 13;9(1):52. doi: 10.1038/s41523-023-00547-w.
7
Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening.种族和民族调整后开始乳腺癌筛查的年龄建议。
JAMA Netw Open. 2023 Apr 3;6(4):e238893. doi: 10.1001/jamanetworkopen.2023.8893.
8
Breast cancer in India: Present scenario and the challenges ahead.印度的乳腺癌：现状与未来挑战。
World J Clin Oncol. 2022 Mar 24;13(3):209-218. doi: 10.5306/wjco.v13.i3.209.
9
Impact of the COVID-19 Pandemic on Breast Cancer Screening and Operative Treatment.COVID-19 大流行对乳腺癌筛查和手术治疗的影响。
Am Surg. 2022 Jun;88(6):1051-1053. doi: 10.1177/00031348221087920. Epub 2022 Apr 13.
10
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.瑞博西林联合来曲唑治疗晚期乳腺癌的总生存期。
N Engl J Med. 2022 Mar 10;386(10):942-950. doi: 10.1056/NEJMoa2114663.
Zotero 插件